EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Randomized controlled pilot study assessing fructose tolerance during fructose reintroduction in non‐constipated irritable bowel syndrome patients successfully treated with a low FODMAP diet

Callie Cuff, Lisa D Lin, Swapna Mahurkar-Joshi, Jonathan P Jacobs, Venu Lagishetty, Nancee Jaffe, Janelle Smith, Tien Dong, Jessica Sohn, Lin Chang iD

Neurogastroenterology & Motility · 2023

DOI: 10.1111/nmo.14575 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Neurogastroenterology & Motility, 2023. Verfasst von Callie Cuff und 9 weiteren Autor:innen. Beteiligte Einrichtung: University of California Los Angeles David Geffen School of Medicine, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: CSRD VA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Limited data exist to guide FODMAP (fermentable oligo‐, di‐, monosaccharides, and polyols) reintroduction to assess tolerance following a low FODMAP diet (LFD). Fructose reintroduction is often stepwise up to 7.5 g fructose (e.g., three tsp of honey). We aimed to determine the fructose tolerance threshold in non‐constipated, LFD‐responsive patients with irritable bowel syndrome (IBS) and assess whether stool microbiome predicted LFD response or fructose tolerance.

Methods

Thirty‐nine non‐constipated IBS patients (51% women, mean age 33.7 years) completed a 4‐week LFD. LFD responders were defined as those who reported adequate relief of IBS symptoms following the LFD. Responders were randomized to one of the three solution groups (100% fructose, 56% fructose/44% glucose, or 100% glucose) and received four doses (2.5, 5, 10, 15 g) for 3 days each. Patients reached their tolerance dose if their mean daily IBS symptom severity (visual analog scale [VAS], 0–100 mm) was >20 mm higher than post‐LFD VAS. Stool samples before and after LFD were analyzed using shotgun metagenomics.

Results

Seventy‐nine percent of patients were LFD responders. Most responders tolerated the 15 g sugar dose. There was no significant difference in mean dose tolerated between solution groups ( p = 0.56). Compared to baseline, microbiome composition (beta diversity) significantly shifted and six bacterial genes in fructose and mannose metabolism pathways decreased after LFD, irrespective of LFD response or the solution group.

Conclusions

Non‐constipated, LFD‐responsive IBS patients should be reintroduced to fructose in higher doses than 15 g to assess tolerance. LFD is associated with significant changes in microbial composition and bacterial genes involved in FODMAP metabolism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Irritable Bowel SyndromeHumansFemaleAdultMaleDisaccharidesOligosaccharidesFructosePilot ProjectsFODMAP DietFermentationGlucoseDiet

Stichwörter der Autor:innen

fructose reintroductionfructose toleranceirritable bowel syndromelow FODMAP diet

Substanzen

DisaccharidesOligosaccharidesFructoseGlucose

Autor:innen und Institutionen

  • University of California Los Angeles David Geffen School of Medicine, Los Angeles, California, USA.
  • Vatche and Tamar Manoukian Division of Digestive Diseases, University of California Los Angeles, Los Angeles, California, USA.
  • G Oppenheimer Center for Neurobiology of Stress and Resilience, Los Angeles, California, USA.
  • UCLA Microbiome Center, David Geffen School of Medicine, Los Angeles, California, USA.
  • Division of Gastroenterology, Hepatology and Parenteral Nutrition, VA Greater Los Angeles Healthcare System, Los Angeles, California, USA.

ORCID-Profile: Lin Chang

Förderung

  • CSRD VA

Zitieren

APA

Cuff, C., Lin, L. D., Mahurkar-Joshi, S., Jacobs, J. P., Lagishetty, V., Jaffe, N., Smith, J., Dong, T., Sohn, J., & Chang, L. (2023). Randomized controlled pilot study assessing fructose tolerance during fructose reintroduction in non‐constipated irritable bowel syndrome patients successfully treated with a low FODMAP diet. Neurogastroenterology & Motility. https://doi.org/10.1111/nmo.14575

Vancouver

Cuff C, Lin LD, Mahurkar-Joshi S, Jacobs JP, Lagishetty V, Jaffe N, et al. Randomized controlled pilot study assessing fructose tolerance during fructose reintroduction in non‐constipated irritable bowel syndrome patients successfully treated with a low FODMAP diet. Neurogastroenterology & Motility. 2023. doi:10.1111/nmo.14575

BibTeX
@article{Cuff2023,
  author = {Cuff, Callie and Lin, Lisa D and Mahurkar-Joshi, Swapna and Jacobs, Jonathan P and Lagishetty, Venu and Jaffe, Nancee and Smith, Janelle and Dong, Tien and Sohn, Jessica and Chang, Lin},
  title = {Randomized controlled pilot study assessing fructose tolerance during fructose reintroduction in non‐constipated irritable bowel syndrome patients successfully treated with a low FODMAP diet},
  journal = {Neurogastroenterology & Motility},
  year = {2023},
  doi = {10.1111/nmo.14575}
}
Kostenlos starten →